Baixe o app para aproveitar ainda mais
Prévia do material em texto
Accepted Manuscript Title: Comparing different post mortem human samples as DNA sources for downstream genotyping and identification Author: Gayvelline C. Calacal Dame Loveliness T. Apaga Jazelyn M. Salvador Joseph Andrew D. Jimenez Ludivino J. Lagat Renato Pio F. Villacorta Maria Cecilia F. Lim Raquel d.R. Fortun Francisco A. Datar Maria Corazon A. De Ungria PII: S1872-4973(15)30051-X DOI: http://dx.doi.org/doi:10.1016/j.fsigen.2015.07.017 Reference: FSIGEN 1395 To appear in: Forensic Science International: Genetics Received date: 23-3-2015 Revised date: 10-7-2015 Accepted date: 21-7-2015 Please cite this article as: G.C. Calacal, D.L.T. Apaga, J.M. Salvador, J.A.D. Jimenez, L.J. Lagat, R.P.F. Villacorta, M.C.F. Lim, R.R. Fortun, F.A. Datar, M.C.A.D. Ungria, Comparing different post mortem human samples as DNA sources for downstream genotyping and identification, Forensic Science International: Genetics (2015), http://dx.doi.org/10.1016/j.fsigen.2015.07.017 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. http://dx.doi.org/doi:10.1016/j.fsigen.2015.07.017 http://dx.doi.org/10.1016/j.fsigen.2015.07.017 Page 1 of 19 Ac ce pt ed M an us cr ip t 1 Comparing different post mortem human samples as DNA sources for downstream 1 genotyping and identification 2 3 Gayvelline C. Calacal 1,2 , Dame Loveliness T. Apaga 2 , Jazelyn M. Salvador 1,2 , Joseph Andrew D. 4 Jimenez 3 , Ludivino J. Lagat 3 , Renato Pio F. Villacorta 4 , Maria Cecilia F. Lim 5 , Raquel dR. 5 Fortun 5 , Francisco A. Datar 6 and Maria Corazon A. De Ungria 1,2 6 7 1 DNA Analysis Laboratory, Natural Sciences Research Institute, University of the Philippines, 8 Diliman, Quezon City, Philippines; 9 2 Program on Forensics and Ethnicity, Philippine Genome Center, National Science Complex, 10 University of the Philippines, Diliman, Quezon City, Philippines; 11 3 Forensic Center, Commission on Human Rights, Central Office, Philippines; 12 4 Department of Anatomy, College of Medicine, University of the Philippines, Manila, 13 Philippines; 14 5 Department of Pathology, College of Medicine, University of the Philippines, Manila, 15 Philippines; 16 6 Department of Anthropology, College of Social Science and Philosophy, University of the 17 Philippines, Diliman, Quezon City, Philippines 18 19 20 Additional Information and Reprint Requests: 21 Gayvelline C. Calacal, RMT, MSc 22 DNA Analysis Laboratory, Natural Sciences Research Institute 23 University of the Philippines Diliman 24 Quezon City 1101, Philippines 25 gcalacal@gmail.com 26 27 28 29 30 31 Title Page (with Author Details) Page 2 of 19 Ac ce pt ed M an us cr ip t DNA analysis of several samples from various postmortem and environmental conditions Complete DNA profiles were generated from bone marrow, femur, metatarsal and patella Amplifiable DNA can be generated from bone marrow transferred on FTA ® card Amplifiable target DNA maybe obtained using 0.1 ng DNA template 0.5 ng DNA template increased allele recovery and improved peak balance *Highlights (for review) Page 3 of 19 Ac ce pt ed M an us cr ip t 1 Abstract 1 2 The capability of DNA laboratories to perform genotyping procedures from post mortem remains, 3 including those that had undergone putrefaction, continues to be a challenge in the Philippines, a 4 country characterized by very humid and warm conditions all year round. These environmental 5 conditions accelerate the decomposition of human remains that were recovered after a disaster 6 and those that were left abandoned after a crime. When considerable tissue decomposition of 7 human remains has taken place, there is no other option but to extract DNA from bone and/or 8 teeth samples. Routinely, femur shafts are obtained from recovered bodies for human 9 identification because the calcium matrix protects the DNA contained in the osteocytes. In the 10 Philippines, there is difficulty in collecting femur samples after natural disasters or even human-11 made disasters, because these events are usually characterized by a large number of fatalities. 12 Identification of casualties is further delayed by limitation in human and material resources. 13 Hence, it is imperative to test other types of biological samples that are easier to collect, transport, 14 process and store. 15 16 We analyzed DNA that were obtained from body fluid, bone marrow, muscle tissue, clavicle, 17 femur, metatarsal, patella, rib and vertebral samples from five (5) recently deceased untreated 18 male cadavers and seven (7) male human remains that were embalmed, buried for ~1 month and 19 then exhumed. The bodies had undergone different environmental conditions and were in various 20 stages of putrefaction. A DNA extraction method utilizing a detergent-washing step followed by 21 an organic procedure was used. The utility of bone marrow and vitreous fluid including bone 22 marrow and vitreous fluid that was transferred on FTA ® cards and subjected to autosomal STR 23 and Y-STR DNA typing were also evaluated. DNA yield was measured and the presence or 24 absence of PCR inhibitors in DNA extracts was assessed using Plexor ® HY. All samples were 25 amplified using PowerPlex ® 21 and PowerPlexY ® 23 systems and analyzed using the AB3500 26 Genetic Analyzer and the GeneMapper ® ID-X v.1.2 software. 27 28 PCR inhibitors were consistently detected in bone marrow, muscle tissue, rib and vertebra 29 samples. Amplifiable DNA were obtained in a majority of the samples analyzed. DNA recovery 30 from 0.1 g biological material was adequate for successful genotyping of most of the non-bone 31 and bone samples. Complete DNA profiles were generated from bone marrow, femur, metatarsal 32 and patella with 0.1 ng DNA template. Using 0.5 ng DNA template resulted in increased allele 33 recovery and improved intra- and inter- locus peak balance. 34 *Manuscript Click here to view linked References http://ees.elsevier.com/fsigen/viewRCResults.aspx?pdf=1&docID=3761&rev=1&fileID=112552&msid={0AD3D693-928F-4E7B-BC6C-03DF68EE6D94} Page 4 of 19 Ac ce pt ed M an us cr ip t 2 Keywords: DNA, human identification, mass disasters, STR typing, putrefied remains 35 36 1. Introduction 37 DNA typing of samples such as bone and teeth that are obtained from putrefied remains is used 38 for human identification after a disaster, during criminal investigations and in resolving parentage 39 disputes involving deceased persons [1-7]. In the Philippines that is characterized by a tropical 40 and humid climate and the presence of about 20 typhoons per year, proper management and 41 processing of human remains for identification is important. For example, Typhoon Haiyan that 42 greatly affected Eastern Visayas in 2014 resulted in at least 6,300 casualties [8]. Many bodies 43 were already decomposed when washed ashore thereby making identification via visual, 44 pathological and DNA examinations extremely difficult. Due to the magnitude of the tragedy, 45 deficient logistic and financial resources and the compromised states of the remains, majority of 46 the bodies were buried without proper identification. The complex political situation in the 47 Philippines associated with an increased number of human-made casualties, e.g. bombing, and 48 extra-judicial killings. From July 2010 to June 2014, there were 204 victims of extrajudicial 49 killing [9]. Many bodies and body partsthat were found in abandoned locations or makeshift 50 graves could not be identified using ordinary means. Hence in these situations, DNA profiling of 51 putrefied remains or skeletonized samples may be the only means to identify their human sources. 52 With the developments in DNA-based parentage testing amongst the living, many persons have 53 likewise resorted to the collection of biological samples from deceased persons with the purpose 54 of resolving parentage or kinship issues [10]. Many post-mortem samples that are submitted for 55 DNA typing have been exposed to varied environmental conditions. These conditions may be 56 associated with the embalming process when formalin (10% formaldehyde) is introduced into the 57 bodies of the deceased, the exposure to lime commonly used to inhibit the decomposition process 58 in mass graves; and contact with soil microorganisms after underground internment. Genotyping 59 of post-mortem samples were reported unsuccessful due to low DNA yield, the presence of 60 inhibitors in DNA preparations and DNA fragmentation/degradation brought about by exposure 61 to harsh environmental conditions and microbial nucleases (1,3,4,11). 62 63 There is a higher success rate of DNA recovery from femur shafts and teeth [3, 11]. Unlike 64 spongy bones, the physical and chemical structure of a compact bone with the calcium matrix 65 provides greater protection for DNA against post-mortem damage [11]. Several studies 66 Page 5 of 19 Ac ce pt ed M an us cr ip t 3 recommended the collection of bone samples from the densest cortical bone especially when 67 handling old skeletal remains for human identification [2, 6, 11]. In the Philippines, there is 68 difficulty in collecting femur samples after natural disasters such as typhoons or even human-69 made disasters such as bombings, because these events are usually characterized by a large 70 number of fatalities. Identification of casualties is further delayed by limitation in human and 71 material resources. Hence, it is imperative to test other types of biological samples that are easier 72 to collect, transport, process and store. 73 74 In the present study, four non-bone (vitreous fluid, bone marrow from clavicle, bone marrow from 75 femur and muscle tissues) and six bone (femur, rib clavicle, vertebra, patella and metatarsal) type 76 samples from recently deceased male persons and male remains with a short one-month post-77 mortem interval were genotyped using autosomal (aSTR) and Y-chromosomal Short Tandem 78 Repeat (Y-STR) markers in order to compare the utility of these samples for human remains 79 identification. 80 81 2. Materials and Methods 82 2.1. DNA sources 83 Human remains from twelve (12) male persons that can be classified into two groups were used in 84 the present study. The first group of human remains consisted of five (5) unidentified cadavers 85 who were recently deceased wherein samples were collected within two (2) to nine (9) days post-86 mortem. These cadavers were sent to the Department of Anatomy, College of Medicine, 87 University of the Philippines, Manila (UPM-CM-DA) immediately after death, and stored at 88 ambient temperature. The second group consisted of seven (7) male embalmed human remains 89 that were exhumed ~1 month after internment by the Commission on Human Rights (CHR). 90 Three (3) cadavers were buried inside individual coffins and interred in above-ground concrete 91 vaults whereas four (4) cadavers were inside individual coffins that were buried below ground. 92 93 Six types of bone samples namely femur, rib, clavicle, vertebra, patella, and metatarsal, were 94 collected from the two groups of human remains. When available, vitreous fluid (VF), bone 95 marrow from femur and clavicle, and muscle tissues were collected from the two groups of male 96 remains. The state of one recently deceased cadaver did not allow for the collection of VF. A 97 Page 6 of 19 Ac ce pt ed M an us cr ip t 4 vertebral sample was also not collected from one cadaver that was interred above ground for ~ 1 98 month due to constraints encountered on site by our collaborating agency (CHR). Blood was 99 collected from the five recently deceased cadavers in order to generate reference DNA profiles. 100 101 This study was approved by University of the Philippines Manila, Research and Ethics Board 102 (2012-0275-P1). 103 104 2.2. Sample processing 105 Heat-stable materials and equipment parts used were decontaminated via autoclaving at 121 o C, 15 106 lb/inch 2 for 15 minutes, whereas heat-labile materials were UV-irradiated for at least 2 hours prior 107 to use. 108 109 Prior to processing, all samples were stored as follows: bone marrow and VF that were transferred 110 on FTA ® cards (Whatman Intl., NJ), were stored at room temperature; blood and vitreous fluid 111 samples collected with or without preservative (EDTA) were stored at 4 o C; and bone, bone 112 marrow and muscle tissue samples were stored at -20 o C. Blood, VF and bone marrow on FTA ® 113 cards were processed after 1-7 days following manufacturer’s instruction. Bone samples were 114 processed following a methodology reported previously [1]. Briefly, each bone sample was de-115 fleshed then air-dried. Dried samples were sanded to remove external contaminants and were cut 116 into 1-2 cm bone fragments using a rotary tool equipped with a new sanding band and cutting 117 disc. Bone cuttings, weighing ~2.0 g, were washed twice in 5%Terg-a-zyme and sonicated for 25 118 minutes. Bone cuttings were washed with sterile distilled water thrice. Additional washes with 119 sterile distilled water were done until no more bubble was observed. Bone samples were dried in 120 the oven at 56°C for 18-24 hours. After drying, bone cuttings were pulverized into fine powder 121 using the Spex CertiPrep 6750 Freezer/Mill Cryogenic Grinder (SPEX SamplePrep LLC, NJ). 122 Muscle tissue samples that were stored at -20 o C, were brought to ambient temperature. Tissue 123 samples were then minced into very fine portions using sterile disposable blades. The following 124 were prepared for DNA extraction: five replicates of 0.1 g bone powder, bone marrow and muscle 125 tissue samples; two replicates of 200 µl VF samples that were stored with or without EDTA. 126 127 2.3. Organic DNA extraction with Microcon YM-100 Concentrators 128 A one (1) ml lysis buffer solution consisting of 790 µL Tris-EDTA-NaCl (10 mmol/L Tris, pH 129 8.0 – 50 mmol/L EDTA, pH 8.0 – 100 mmol/L NaCl) buffer, 100 µL SDS (20%), 40 µL DTT 130 Page 7 of 19 Ac ce pt ed M an us cr ip t 5 (1.0 M) and 70 µL Proteinase K (20 mg/mL), was added to 0.1 g samples, incubated at 56°C for 131 ~24 hours with constant agitation set at 1,200 rpm in a Thermomixer ® comfort (Eppendorf, 132 Hamburg). After incubation, an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1) 133 was added to the lysate. The lysate-PCI preparation was mixed, transferred to a High Density 134 Phase-Lock Gel tube (Qiagen, Hamburg) and centrifuged for two minutes at 14,000 rpm to 135 facilitate the separation of the aqueous and organic layers. The upper aqueous layer was then 136 placed in Microcon YM-100 centrifugal filter units (Millipore, MA), washed once with TE -4 137 buffer and eluted with 40µl TE -4 buffer. 138 139 A similar procedure was used to extract DNA from VF, with slight modifications. 300 µL lysis 140 buffer was added to 200 µL VF, incubated at 56°C for ~17 hours with constant agitation set at 141 1,200 rpm. 500 µL PCI was then added to the lysate and extracted accordingly. 142 143 2.4. DNA quantitation 144 Determination of total human and Y-DNA concentrations and detection of presence of inhibitors 145 from DNA extracts were conducted using the Plexor HY human DNAquantitation kit, reactions 146 were ran in an AB 7500 Real-time PCR system (AB Life Technologies, CA) and analyzed using 147 Plexor HY software v2 (Promega Corporation, WI). DNA concentrations (ng/μl) were multiplied 148 with the elution volume (μL) and divided by the original amount or volume of sample in order to 149 calculate DNA yield (ng) per initial weight of sample (g) or volume of fluid samples (μL). 150 151 2.5. Autosomal STR (aSTR) and Y-chromosomal STR (YSTR) DNA profiling 152 Amplifications of aSTRs and Y-STRs were performed using PowerPlex ® 21 (PP21) and 153 PowerPlex ® Y 23 (PPY23) (Promega Corporation), respectively, in reduced PCR reaction 154 volumes. Two DNA template masses (0.1 ng and 0.5 ng) of bone and non-bone sample types, 155 when applicable, per 12.5 μL reaction volume were used to compare the utility of different 156 sample types as source of DNA for genotyping. Undiluted DNA extracts were amplified when 157 estimated DNA concentration of a preparation is very low. Amplifications were done in a PE 158 9700 thermocycler (AB Life Technologies) following manufacturer's instructions. Amplified 159 products were separated via capillary electrophoresis and detected in an ABI PRISM 3500 160 Page 8 of 19 Ac ce pt ed M an us cr ip t 6 Genetic Analyzer using GeneMapper ® ID-X v.1.2 software (AB Life Technologies), according to 161 manufacturer’s recommended protocols. Allele designations were determined by comparison of 162 the amplified DNA fragments with the allelic ladders supplied in the respective kits. 163 164 The following parameters were evaluated to measure PCR success: 1) DNA yield; 2) peak height 165 (PH) values in relative fluorescent units (RFU); 3) total allele recovery expressed as percentage of 166 alleles generated compared to total expected alleles observed across all aSTR markers, with 167 minimum peak height set at 50 rfu,; and 4) peak height ratio (PHR) in heterozygous alleles, 168 defined as the smaller peak/larger peak. In untreated recently deceased samples, reference 169 genotypes obtained from blood samples were compared with the DNA profiles that were 170 generated using different sample types. In the absence of a reference sample and DNA profile in 171 embalmed/exhumed remains, a consensus DNA profile was used as the reference DNA profile for 172 each cadaver. 173 174 Page 9 of 19 Ac ce pt ed M an us cr ip t 7 3. Results and Discussion 175 3.1. DNA yield 176 The average DNA yield of each sample type for untreated/unburied and embalmed/exhumed 177 human remains (Figure 1). 178 179 Figure 1. DNA yield of samples obtained from (A) untreated/unburied (B) embalmed/buried above ground and (C) 180 embalmed/buried below ground human remains. 181 182 Overall, sufficient amounts of DNA were recovered from bone samples even without a 183 decalcification step. The removal of this step in the preparation of bone samples for DNA 184 extraction, streamlines the entire bone processing procedures. Results of real-time assays showed 185 Page 10 of 19 Ac ce pt ed M an us cr ip t 8 sufficient bone and non-bone DNA for subsequent genotyping were extracted from 0.1 g samples 186 using organic based DNA extraction procedures. On the other hand, DNA extraction was not 187 successful using vitreous fluid (VF) samples from embalmed/exhumed remains. It is possible that 188 the fluid samples that were recovered from embalmed remains were mostly formalin. In contrast, 189 vitreous fluid with or without EDTA from recently deceased cadavers that were not embalmed 190 yielded varying amounts of DNA. Hence, vitreous fluid from untreated bodies may be a suitable 191 source of DNA for human remains identification. Compared to bone and tissue samples, VF 192 samples are much easier to collect, transport and process in a mass disaster scenario. 193 194 DNA yield >1 ng/0.1g sample was obtained in 95% of the extracts. Generally, a lower DNA yield 195 was observed in samples obtained from three human remains that were interred above ground. 196 The presence of inhibitors was more consistently detected in samples (bone marrow, muscle 197 tissue, rib and vertebra) from human remains with below ground burial. Detection of inhibitors 198 may be related to soil contaminants and degradation products due to microbial activity that were 199 not completely removed even after organic (PCI) purification. 200 201 3.2. Allele recovery 202 Complete DNA profiles were generated with 0.1 ng DNA template in 12.5 µL PCR reaction 203 volume. Increasing DNA template to 0.5 ng improved allele recovery by 10-50% (Figure 2a-c). 204 Amplifiable DNA with interpretable profiles was recovered in a majority of the samples analyzed 205 even after formalin treatment and buried for ~ 1 month (Fig 2b-c). Our results show that formalin 206 treatment in human remains has limited effect on the recovery and amplification of DNA in bone 207 and muscle tissue samples. This is evidenced by a DNA yield >1ng per 0.1g original sample in 208 majority of the extracts and the generation of complete STR DNA profiles. Partial profiles are 209 likely due to insufficient target DNA (amplicons up to ~500 bp) amplified rather than DNA 210 concentration. 211 212 Page 11 of 19 Ac ce pt ed M an us cr ip t 9 Allele Recovery (%) 213 A: untreated/unburied human remains 214 215 216 217 Page 12 of 19 Ac ce pt ed M an us cr ip t 10 B: embalmed/buried above ground 218 219 220 221 Page 13 of 19 Ac ce pt ed M an us cr ip t 11 C: embalmed/buried below ground 222 223 224 225 Page 14 of 19 Ac ce pt ed M an us cr ip t 12 Figure 2. Autosomal and Y-STR alleles recovered (%) for each sample type. Comparison made between samples 226 obtained from human remains that are (A) untreated/unburied (B) embalmed/buried above ground (C) embalmed/ 227 buried below ground using two DNA template mass (0.1 and 0.5 ng) and on FTA in 12.5 µL reaction. 228 229 Amplifiable target DNA (amplicons up to ~500 bp) suitable for aSTR and Y-STR DNA analysis 230 was recovered from 0.1 g sample. Our data suggest that adequate quantities of DNA can be 231 recovered from 0.1 g bone and non-bone material. Results of this study provide further empirical 232 data supporting previous observations [12] that a small amount of bone starting material may be 233 used for nuclear typing and appeared to performed better during amplification due to reduction in 234 inhibition problems. Hence, small bone samples such as metatarsal and patella are also good 235 DNA sources and should be collected during autopsy. 236 237 DNA extracts from post mortem samples collected from untreated recently deceased cadavers 238 showed similar DNA typing results regardless of the sample type use. For more challenged 239 samples such as those collected from human remains that were embalmed and buried, data 240 showed consistently higher allele recoveries from femur and bone marrow obtained from femur. 241 In addition, complete to nearly complete profiles (>60%) were obtained from smaller and easier 242 to collect bone types such as patella and metatarsal bones. 243 244 Routine genotyping procedures have preferentially used compact bones as starting material for 245 human remains identification. It was previously reported [11] that general trends in success rates 246 of DNA analyses were observed with respect to the type of bone tested with the highest success 247 rates observed with samples from dense cortical weight bearing leg bones, particularly with femur 248 (86.9%), followed by teeth samples, with the lowest success rate from clavicle, ulna and radius. 249 Bones that performed less tend to be less dense and/or have a greater proportion of spongy diploic 250 bone. Here we have shown thatamplifiable nuclear DNA can be recovered consistently from 251 femur and bone marrow samples. Depending on the condition of the samples, complete profiles 252 can also be generated from foot and patella bone. Thus, these bone sample types could be used as 253 an alternative DNA source when analyzing human remains. This is especially useful if the 254 collection of femur bones is impractical due to the invasiveness of the procedure and the difficulty 255 of obtaining these samples from a highly rigid, intact embalmed body. We succeeded in obtaining 256 good quality DNA profiles from small and less compact bone samples such as patella and 257 metatarsal (foot bone), similar to earlier reports [7, 13, 14]. There was an observed difference in 258 allele recoveries dependent on the burial condition of the cadavers. Hence, the variability 259 Page 15 of 19 Ac ce pt ed M an us cr ip t 13 observed warrants further investigation if this bone type is to be used as a standard routine sample 260 for disaster victim identification. 261 262 Results also show that amplifiable DNA can be generated from bone marrow taken from femur 263 samples and transferred on FTA ® card which are cost efficient and easier to process. Complete to 264 nearly complete (>80%) genetic profiles were recovered from bone marrow samples on FTA ® 265 from recently deceased/ unburied and those that were embalmed / buried below-ground with 266 relatively balanced peaks for both aSTR and Y-STR DNA typing systems (Figure 3) whereas, no 267 profile was observed for bone marrow samples buried above-ground. 268 269 Bone marrow (femur) extracted via organic extraction method 270 (A) Autosomal STR 271 272 (B) Y-STR 273 274 275 Bone marrow (femur) on FTA ® card 276 (C) Autosomal STR 277 278 279 280 281 282 Page 16 of 19 Ac ce pt ed M an us cr ip t 14 (D) Y-STR 283 284 Figure 3. Representative electropherograms showing aSTR (A, C) and Y-STR (B, D) profiles from bone marrow 285 (femur) samples obtained from human remains buried below ground extracted via organic procedure and using FTA ® 286 technology. All expected alleles were generated with relatively balance peak signals. 287 288 Variation in allele recoveries for above ground vs. below ground bone marrow samples on FTA ® 289 can be related to the consistency of bone marrow and efficiency of transfer of samples onto the 290 FTA ® card. Bone marrow samples taken from human remains in above-ground concrete vaults 291 were drier and more difficult to transfer onto FTA ® cards, hence sample transfer was inefficient. 292 293 3.3. Peak Height and Peak height Ratio of Heterozygous Alleles 294 From post mortem samples included in this report, we efficiently amplified DNA extracts 295 utilizing ~0.1 ng or greater initial DNA template load using PP21 and PPY23 multiplex system. 296 Davoren and co-workers [15] reported successful amplification in bone DNA extracts generating 297 complete aSTR profile with PowerPlex 16 using ≥150 pg DNA, whereas in another report, 298 amplification of 100 pg or less DNA reproducible results with anticipated stochastic effects using 299 the AmpFISTR Identifiler system [16]. Loss of heterozygosity and locus dropouts were most 300 observed using 0.1 ng of starting DNA template. Increasing DNA template to 0.5 ng in 12.5 µL 301 PCR reaction volume improved peak signals. Majority of scatter plot points clustered in the right 302 quadrant indicating relatively balanced peaks in heterozygote alleles using 0.5 ng DNA template 303 mass (Figure 4). With reduce template quantity in the PCR reaction (≤ 0.1 ng), stochastic effects 304 such as allelic dropout and drop-in, intra and interlocus imbalance and poor spectral resolution i.e. 305 stutter and bleedthroughs are some of the problems often encountered [16, 17, 18]. Although 306 each replicate is equally likely to exhibit random artifacts, it is favorable to do multiple 307 amplifications to clarify stochastic effects brought about by low template quantity and report 308 consensus alleles generated from replicate analysis as recommended [16,17]. 309 Page 17 of 19 Ac ce pt ed M an us cr ip t 15 310 Figure 4. Peak height (major peak) and heterozygote balance. Scatter plots of the minor peak to major peak ratio (in 311 RFUs) using 0.1 ng and 0.5 ng DNA template. Specific loci evaluated include only those markers for which at least 312 one of the two expected alleles was present in a given DNA profile. For allele dropouts, the PHR = 0. 313 314 4. Conclusion 315 We were able to recover and amplify DNA from bone samples taken from recently deceased 316 untreated cadavers and embalmed/exhumed human remains using methods described here. 317 Complete DNA profiles were generated from femur, bone marrow from femur, metatarsal and 318 patella. If available, bone marrow and vitreous fluid samples can be used for genotyping, which is 319 more cost-efficient for mass disaster identification efforts. The data also indicates that smaller 320 bones such as patella and metatarsal (foot bone) which are thought to be poor DNA sources 321 before can be utilized as alternative sources of DNA for STR typing. Amplifiable target DNA 322 maybe obtained using 0.1 ng of DNA, increasing DNA template to 0.5 ng in 12.5 µL PCR 323 reaction volume significantly improves allele recovery to up to 50% more, with interpretable and 324 relatively balanced inter-locus peak signals. These results have clear implications in the 325 identification of disaster victims, in situations where bone samples are used as DNA source. 326 327 328 Acknowledgements 329 The project was supported by the Philippine Council for Health Research and Development-330 Department of Science and Technology (PCHRD-DOST) (FP:120044), the Philippine Genome 331 Center and the Natural Sciences Research Institute, University of the Philippines, Diliman. We 332 0 .0 0 .2 0 .4 0 .6 0 .8 1 .0 0 1 0 0 0 0 2 0 0 0 0 3 0 0 0 0 4 0 0 0 0 P e a k H e ig h t R a tio M a j o r P e a k H e i g h t A :0 .1 n g D N A te m p la te 0 .0 0 .2 0 .4 0 .6 0 .8 1 .0 0 1 0 0 0 0 2 0 0 0 0 3 0 0 0 0 4 0 0 0 0 P e a k H e ig h t R a tio M a j o r P e a k H e i g h t B :0 .5 n g D N A te m p la te Page 18 of 19 Ac ce pt ed M an us cr ip t 16 thank Miriam Ruth M. Dalet, Minerva S. Sagum, Maria Lourdes D. Honrado and Paul Ryan L. 333 Sales for their excellent technical support and Frederick C. Delfin for his valuable insights during 334 the preparation of the manuscript. The authors acknowledged Kelly Baroga (UP-College of 335 Medicine-Department of Anatomy) and the Commission on Human Rights-Forensic Center staff 336 for their assistance during sample collection. 337 338 339 References 340 341 [1] Budimlija ZM, Prinz MK, Zelson-Mundorff A, Wiersema J, Bartelink E, MacKinnon G, 342 Nazzaraulo BL, Estacio SM, Hennessey MJ, Schaler, RC. 2003. World Trade Center human 343 identification project: experiences with individual body identification cases. Croatian Medical 344 Journal. 44(3):259-263. 345 [2] Edson SM, Ross JP, Coble MD, Parson TJ, Barrit SM, Christensen AF, Holland TD. 2004. 346 Naming the Dead: confronting the realities of rapid identification of degraded skeletal remains. 347 Forensic Science Review.16(1):63-90. 348 [3] Andelinović S, Sutlović D, Erceg Ivkosić I, Skaro V, Ivkosić A, Paić F, Rezić B, Definis-349 Gojanović M, Primorac D. 2005. Twelve-year experience in identification of skeletal remains 350 from mass graves. Croatian Medical Journal. 46(4):530-539. 351 [4] Alonso A, Martín P, Albarrán C, García P, Fernández de Simón L, Iturralde MJ, Fernández-352 Rodríguez A, Atienza I, Capilla J, García-Hirschfeld J, Martínez P, Vallejo G, García O, García 353 E, Real P, Álvarez D, LenA, Sancho M. 2005. Challenges of DNA Profiling in Mass Disaster 354 Investigations. Croatian Medical Journal. 46(4):540-548. 355 [5] Coble MD, Loreille OM, Wadhams MJ, Edson SM, Maynard K, Meyer CE, Niederstätter H, 356 Berger C, Berger B, Falsetti AB, Gill P, Parson W, Finelli LN. 2009. Mystery solved: the 357 identification of the two missing Romanov children using DNA analysis. PLoS One. 4(3):e4838. 358 359 [6] Prinz M, Carracedo A, Mayr WR, Morling N, Parsons TJ, Sajantila A, Scheithauer R, 360 Schmitter H, Schneider PM. 2007. DNA Commission of the International Society for Forensic 361 Genetics (ISFG): recommendations regarding the role of forensic genetics for disaster victim 362 identification (DVI). Forensic Science International Genetics. 1(1):3-12. 363 [7] Mundorf AZ, Bartelink EM, Mar-Cash EM. 2009. DNA preservation in skeletal elements 364 from the World Trade Center Disaster: Recommendation for mass fatality management. Journal 365 of Forensic Science. 54(4):739-745. 366 [8] NDRRMC Update: Situation Report Re: Effects of Typhoon “Yolanda” (Haiyan). 2014. 367 National Disaster Risk Reduction and Management Council, Philippines. Retrieved April, 17, 368 2014. 369 [9] KARAPATAN (Alliance for the Advancement of People’s Rights). KARAPATAN Monitor. 370 2014. KARAPATAN. Quezon City, Philippines. 371 http://www.ncbi.nlm.nih.gov/pubmed?term=%22Andelinovi%C4%87%20S%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Sutlovi%C4%87%20D%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Erceg%20Ivkosi%C4%87%20I%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Skaro%20V%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Ivkosi%C4%87%20A%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Pai%C4%87%20F%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Rezi%C4%87%20B%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Definis-Gojanovi%C4%87%20M%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Definis-Gojanovi%C4%87%20M%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Primorac%20D%22%5BAuthor%5D javascript:AL_get(this,%20'jour',%20'Croat%20Med%20J.'); javascript:AL_get(this,%20'jour',%20'Croat%20Med%20J.'); http://www.ncbi.nlm.nih.gov/pubmed?term=%22Coble%20MD%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Loreille%20OM%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Wadhams%20MJ%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Edson%20SM%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Maynard%20K%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Meyer%20CE%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Niederst%C3%A4tter%20H%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Berger%20C%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Berger%20B%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Falsetti%20AB%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Gill%20P%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Parson%20W%22%5BAuthor%5D http://www.ncbi.nlm.nih.gov/pubmed?term=%22Finelli%20LN%22%5BAuthor%5D javascript:AL_get(this,%20'jour',%20'PLoS%20One.'); http://www.ncbi.nlm.nih.gov/pubmed/19083722 http://www.ncbi.nlm.nih.gov/pubmed/19083722 http://www.ncbi.nlm.nih.gov/pubmed/19083722 Page 19 of 19 Ac ce pt ed M an us cr ip t 17 [10] De Ungria MCA, Calacal GC, Delfin FC, Tabbada KA, Salvador JM, Sagum MS, Dalet 372 MRM, Franco SAEL, Maiquilla SMB, Perdigon HB, Villamor LP, Halos SC. 2008. Forensic 373 DNA testing by the UP-NSRI DNA Analysis Laboratory. Acta Medica Philippina. 42(2):38-42. 374 [11] Milos A, Selmanović A, Smajlović L, Huel RL, Katzmarzyk C, Rizvić A, Parsons TJ. 2007. 375 Success rates of nuclear short tandem repeat typing from different skeletal elements. Croatian 376 Medical Journal. 48(4):486-493. 377 [12] Loreille O, Diegoli TM, Irwin JA, Coble MD, and Parsons TJ. 2007. High efficiency DNA 378 extraction from bone by total demineralization. Forensic Science International: Genetics. 1:191-379 195. 380 [13] Ferreira STG, Garrido RG, Paula KA, Nogueira RC, Oliveira ES, Moraes AV. 2013. 381 Cartilage and phalanges from hallux: Alternative sources of samples for DNA typing in disaster 382 victim identification (DVI). A comparative study. Forensic Science International: Genetics. 383 Supplement Series. 4:e366-367. 384 [14] Amory S, Vennemeyer M, Sarajilic M, Huel R, Bilic A, Parsons T. 2013. Improved sampling 385 strategy for DNA typing of skeletal remains in missing persons casework. Abstract for the 25 th 386 Congress of the International Society for Forensic Genetics. 2-7 September 2013 Melbourne, 387 Australia. 388 [15] Davoren J, Vanek D, Konjhodzić R, Crews J, Huffine E, Parsons TJ. 2007. Highly effective 389 DNA extraction method for nuclear short tandem repeat testing of skeletal remains from mass 390 graves. Croatian Medical Journal. 48(4):478-485. 391 [16] Caragine T, Mikulasovich R, Tamariz J, Bajda E, Sebestyen J, Baum H, Prinz M. 2009. 392 Validation of testing and interpretation protocols for low template DNA samples using 393 AmpFlSTR Identifiler. Croatian Medical Journal. 50(3):250-267 394 [17] Gill P, Whitaker J, Flaxman C, Brown N, Buckleton J. 2000. An investigation of the rigor of 395 interpretation rules for STRs derived from less than 100 pg of DNA. Forensic Science 396 International. 112:17-40. 397 [18] Budowle B, Eisenberg AJ, van Daal A. 2009. Validity of low copy number typing and 398 applications to forensic science. Croatian Medical Journal. 50(3):207-217. 399 400 Disclaimers 401 None 402 403 Conflict(s) of interest 404 None 405 406 407 http://www.ncbi.nlm.nih.gov/pubmed/17696303 javascript:AL_get(this,%20'jour',%20'Croat%20Med%20J.'); javascript:AL_get(this,%20'jour',%20'Croat%20Med%20J.'); http://www.ncbi.nlm.nih.gov/pubmed/17696302 http://www.ncbi.nlm.nih.gov/pubmed/17696302 http://www.ncbi.nlm.nih.gov/pubmed/17696302 http://www.ncbi.nlm.nih.gov/pubmed/19480021 http://www.ncbi.nlm.nih.gov/pubmed/19480021 http://www.ncbi.nlm.nih.gov/pubmed/19480017 http://www.ncbi.nlm.nih.gov/pubmed/19480017
Compartilhar